Advertisements

Amoxicilina Rowe

Quick links to important sections

Amoxicilina Rowe

Advertisements

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Amoxicilina Rowe

Understanding Amoxicilina Rowe

Amoxicilina Rowe is a pharmaceutical formulation containing amoxicillin, which is a moderate-spectrum antibiotic belonging to the penicillin group. It is classified as a beta-lactam antibiotic, a category of medications characterized by a specific chemical structure known as a beta-lactam ring. This medication is primarily utilized to address various bacterial infections by interfering with the physiological processes of susceptible microorganisms.

Pharmacological Classification and Mechanism

As a semi-synthetic derivative of penicillin, the active component in Amoxicilina Rowe works through a bactericidal mechanism. This means that it acts by directly causing the death of bacteria rather than merely inhibiting their growth. It achieves this by preventing the synthesis of the bacterial cell wall. During the stage of active multiplication, the medication binds to specific proteins within the bacterial cell, leading to the weakening of the cell wall and eventual rupture of the organism.

Therapeutic Applications

Amoxicilina Rowe is indicated for the treatment of infections caused by specific strains of Gram-positive and Gram-negative bacteria. Because it is an antibiotic, its efficacy is strictly limited to bacterial pathogens; it is not effective against viral infections such as the common cold or influenza.

Common areas of application include:

  • Respiratory Tract Infections: Addressing bacteria affecting the upper and lower respiratory systems.
  • Ear, Nose, and Throat Infections: Targeting localized bacterial growth in these regions.
  • Genitourinary Tract Infections: Managing infections within the urinary or reproductive systems caused by susceptible organisms.
  • Skin and Soft Tissue Infections: Treating bacterial complications affecting the dermis and underlying tissues.

Composition and Presence

The medication is typically available in various forms, such as capsules or oral suspensions, to accommodate different patient needs. While the primary active ingredient is amoxicillin, the formulation may include various excipients that assist in the stabilization, preservation, and delivery of the drug. The "Rowe" designation refers to the specific manufacturer responsible for this particular branded generic version of the antibiotic.

Regulatory References

  1. Amoxicillin: MedlinePlus Drug Information
  2. Amoxicillin Label - DailyMed
Advertisements

What side effects are possible with Amoxicilina Rowe?

Possible Side Effects and Safety Information

This section outlines the adverse reactions and safety characteristics of Amoxicillin as documented in official government regulatory sources, classified by frequency and affected body system.

Frequency-Classified Adverse Reactions

Side effects are categorized by their reported incidence in regulatory documents:

  • Common: Reactions that are frequently reported include diarrhea, nausea, and rash.
  • Uncommon: Effects documented less frequently include vomiting and urticaria (hives).
  • Very Rare: This category covers severe events such as agranulocytosis (severe drop in white blood cells), hemolytic anemia, and severe cutaneous reactions.

System-Organ-Class Safety Groups

Adverse reactions are grouped by the physiological system affected, following standard regulatory classifications:

System-Organ Class Examples of Documented Effects
Gastrointestinal Diarrhea, Nausea, Vomiting, Pseudomembranous colitis
Skin and Subcutaneous Tissue Rash, Urticaria, Severe Cutaneous Reactions (e.g., SJS)
Blood and Lymphatic Anemia, Leukopenia, Thrombocytopenia
Hepatobiliary Hepatitis, Cholestatic jaundice
Immune System Anaphylaxis, Angioedema

Serious Adverse Reactions and Safety Restrictions

Regulatory sources highlight the risk of anaphylactic shock and other severe hypersensitivity reactions, which are recognized safety concerns for the penicillin class. Severe cutaneous adverse reactions and pseudomembranous colitis are also documented as serious adverse events. The medicine is contraindicated in patients with a history of hypersensitivity to penicillin antibiotics or other beta-lactam agents. Additionally, specific safety considerations apply to patients with renal impairment, often necessitating monitoring due to the drug’s primary elimination route, and in those with infectious mononucleosis, where a non-allergic rash is highly likely. The onset of rash may appear more frequently during the initial phase of treatment.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documentation details specific manifestations and actions required in the event of an overdose of Amoxicillin (the active ingredient in Amoxicilina Rowe). This information is strictly based on data from governmental health authorities.


Documented Overdose Presentations

Overdosage may manifest with gastrointestinal symptoms, including nausea, vomiting, and diarrhoea. More severe presentations, particularly with high doses, include neurological effects such as convulsions and dizziness. A critical, officially cited risk is the development of Amoxicillin crystalluria, which can lead to acute renal failure if left unmanaged, especially in patients with pre-existing impaired renal function.


Required Emergency Actions

Immediate medical attention must be sought for any suspected severe overdose or for the occurrence of serious hypersensitivity reactions, such as anaphylaxis, which require immediate emergency treatment.

Regulatory documents outline that management is symptomatic and supportive. Official procedures include ensuring the maintenance of adequate fluid intake and urinary output to reduce the risk of crystalluria. For severe cases, haemodialysis is described as a measure that can remove the drug from the bloodstream. Official guidance also advises discontinuing the medication and commencing appropriate supportive treatment.

Advertisements

Therapeutic Uses of Amoxicilina Rowe

What Amoxicilina Rowe treats: main uses and benefits

This section details the primary conditions and symptom patterns that Amoxicilina Rowe is used to address, focusing on the therapeutic benefit associated with addressing the underlying bacterial infection. The active ingredient, amoxicillin, is commonly used to treat a wide array of infections caused by susceptible bacteria.


Easing Discomfort in Acute Ear, Nose, and Throat Infections

Amoxicilina Rowe is commonly applied in clinical settings that involve acute or disruptive symptom patterns affecting the respiratory tract and head/neck area. It is relevant in conditions such as acute otitis media, bacterial sinusitis, streptococcal pharyngitis, and certain lower respiratory tract infections. Successful treatment may assist with a reduction in localized pain and symptoms related to inflammatory or irritative states, assisting in easing discomfort associated with these acute episodes, where symptoms often interfere with daily functioning.

“This medicine is considered relevant when supportive symptom management is appropriate in contexts involving heightened systemic burden.”


Relief from Systemic Symptom Clusters and Specific Contexts

This medicine supports the handling of symptoms related to systemic imbalance and localized irritative states across several body systems, including the skin and genitourinary tract. When groups of symptoms appear suddenly or fluctuate, such as fever and generalized malaise, the medication plays a role in managing these manifestations. It is also used in specific regimens for managing H. pylori bacteria and applied for supporting mitigation of risk in patients requiring prevention of endocarditis prior to certain medical procedures. The application of this medication, when appropriate, may assist in managing the groups of symptoms, which supports general well-being during symptomatic phases and assists with maintaining functional stability.

Quick Fact: Focus on Managing Inflammatory Symptoms

Amoxicilina Rowe is commonly used to help manage acute symptoms of bacterial infection that present with fever, localized swelling, and pain, offers symptomatic relief that helps patients cope more steadily when symptoms interfere with routine activities.

Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Amoxicilina Rowe?

The eligibility for using Amoxicilina Rowe is strictly determined by official regulatory documents, primarily based on patient history, age, and existing medical conditions.


Absolute Contraindications

The medicine is contraindicated and must not be used by any individual with a history of a severe hypersensitivity reaction (e.g., anaphylaxis, severe rash) to the active ingredient, Amoxicillin, or to any other Beta-Lactam antibiotic (such as other penicillins or cephalosporins).


Age and Condition-Specific Restrictions

Population/Condition Eligibility Status Restriction/Limitation
Allergy to beta-Lactams CONTRAINDICATED Absolute prohibition due to severe allergy risk.
Infectious Mononucleosis NOT RECOMMENDED Use should be avoided due to the high risk of a non-allergic maculopapular rash.
Severe Renal Impairment CONDITIONAL USE Requires caution and may necessitate adjustments to the regimen.
Neonates and Infants (le 3 months) CONDITIONAL USE Requires specific maximum doses due to incompletely developed kidney function.
Pregnancy/Lactation COMPATIBLE Generally considered acceptable when clearly needed, though caution is advised during breastfeeding.

Eligibility is established for all other populations, including children, adolescents, and adults, under standard labeled conditions, provided no contraindications are present.

Advertisements

What should I know about interactions with other medicines?

The documented interaction profile for Amoxicillin is defined by changes in drug exposure and specific pharmacodynamic effects, primarily involving co-administered medications. Medicinal product categories identified in regulatory labeling include Oral Anticoagulants, Uricosuric agents, and select Bacteriostatic Antibacterials.

Interacting Substance Official Interaction Statement
Probenecid Co-administration is not recommended; it decreases renal clearance resulting in increased and prolonged blood levels of Amoxicillin.
Oral Anticoagulants Concomitant use may increase the prolongation of prothrombin time (INR).
Allopurinol Concurrent administration increases the incidence of rash.
Methotrexate Amoxicillin increases the systemic concentration of Methotrexate.
Oral Contraceptives The medication may reduce the efficacy of combined estrogen/progesterone contraceptives.
Other Antibacterials Bacteriostatic antibacterials may interfere with the bactericidal effects.

The interaction structure also includes procedural and context-based constraints. High concentrations of Amoxicillin in the urine may result in false-positive reactions when utilizing non-enzymatic urine glucose tests (e.g., CLINITEST®). Additionally, use of this drug may reduce the effectiveness of the Live Attenuated Typhoid Vaccine, requiring consideration for appropriate timing separation.

The regulatory documents classify these as clinically relevant interactions requiring caution or avoidance, based on their potential to modify drug exposure or efficacy of co-administered medicines.

Advertisements

Mechanism of Action

Targeting the Bacterial Cell Wall (Peptidoglycan Synthesis)

This domain focuses on Amoxicilina Rowe's primary target: the Penicillin-Binding Proteins (PBPs), which are bacterial transpeptidases. The drug acts as an irreversible inhibitor, blocking the final step of peptidoglycan cross-linking essential for structural integrity. This mechanistic blockade leads to cell lysis and death.


Modulating the Lytic Mechanistic Cascade

This mechanism involves a rapid sequence of events: inhibition of PBPs leads to a critically weakened cell wall, causing the bacteria to succumb to osmotic pressure and even activate their own autolytic enzymes. The resulting physiological effect is the disruption and lysis of the bacterial cell, which is the consequential effect of the mechanism.


Specificity to Non-Host Pathways

The drug's activity is highly specific, targeting the bacterial cell wall synthesis pathway that is completely absent in human cells. This specificity ensures the mechanism is selectively toxic. The resulting physiological effect is the destruction of the pathogenic bacteria, achieved through non-engagement with eukaryotic physiological systems.

Advertisements

Dosage and Administration Information

Amoxicilina Rowe, containing amoxicillin, is generally administered through the oral route using capsules, tablets, or an oral suspension, which is the standard pattern for outpatient use. The medicine is also approved for intravenous (IV) administration using a powder for injection when severe infection or patient inability prevents oral intake.

The official adult oral dosing schedule ranges from 750 mg to 1750 mg per day, delivered in divided doses. This generally translates to administration every 8 hours (three times daily) or every 12 hours (twice daily), with the specific strength, such as 500 mg or 875 mg, determined by the clinical context. For specific conditions like uncomplicated gonorrhea, a distinct 3-gram single oral dose is the established regimen.

The medicine may be taken with or without food as its absorption is not significantly affected by meals. If using the oral suspension form, the powder requires reconstitution by adding the designated volume of water and must be shaken well prior to measuring each dose.

The duration of use is strictly defined; treatment must typically be extended for at least 48 to 72 hours after symptoms resolve, and a mandatory 10-day course is required for infections caused by Streptococcus pyogenes to complete the regimen.

Adherence to specific adjustments is required for certain patient groups. Individuals with severe renal impairment (Glomerular Filtration Rate < 30 mL/min) require a reduction in dosage and/or an extension of the time interval between doses; the 875 mg tablet strength is officially prohibited in this population. Pediatric dosing for children over three months is weight-based (e.g., 20 to 45 mg/kg/day) and also administered in divided doses.

Advertisements

Recent Clinical Evidence

Evidence for Acute Ear, Nose, and Throat Infections

The research foundation for treating common conditions like Acute Otitis Media (AOM) and Streptococcal Pharyngitis (Strep Throat) is based on Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews. These studies involved measuring the evolution of symptoms such as pain and fever over time, as well as the measurement of bacterial presence. Research has explored the use of the medicine across pediatric patients (children) and adults, monitoring how symptoms evolved and assessing re-treatment rates. Findings describe observed patterns, but consistency across studies can be complex due to varying criteria for defining a successful outcome. The research base on bacterial clearance and examined rates of potential longer-term complications is substantial.


Evidence for Lower Respiratory and Systemic Infections

Research on the use of this medicine in Community-Acquired Pneumonia (CAP), particularly non-severe cases, relies on RCTs and Meta-analyses that explored short-term changes in symptoms and rates of clinical response. The medicine is also used as a necessary component in complex multi-drug regimens for eradicating the H. pylori bacteria. In this context, research monitors specific bacteriological eradication rates 4 to 8 weeks after the cessation of the regimen. Findings indicate that these reported eradication rates appear dependent on the local patterns of antibiotic resistance to companion drugs.


Evidence Gaps and Follow-up Limitations

Research regarding Infectious Endocarditis Prophylaxis is distinct, relying primarily on Observational Studies and Consensus Statements rather than RCTs, meaning certainty remains low. Furthermore, while research has explored short-term outcomes, the long-term effects are not fully established across all indications, as follow-up durations were often limited to assessing acute episode resolution and recurrence rates. Data also remain insufficient for certain specific patient groups, such as older adults with comorbid conditions, though the research base for pediatric patients is substantial. Evidence quality varies, and data are still emerging regarding optimal treatment durations and comparative outcomes against certain augmented forms of the medicine.

Key Studies & References

  1. AMOXICILLIN - WHO Manual for Procurement & Supply of Quality-Assured MNCH Commodities (Reference for CAP/Pneumonia use)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Amoxicilina Rowe (FAQ)


Q: Can Amoxicilina Rowe be used during pregnancy? (Descriptive classification)

A: Official regulatory labels classify the active ingredient, amoxicillin, as Pregnancy Category B. This designation is generally descriptive of animal studies showing no harm. However, it also indicates that controlled studies specifically in pregnant women are not available.


Q: How quickly does Amoxicilina Rowe start to work?

A: While regulatory information does not state an exact time, studies monitor the evolution of symptoms, such as pain or fever, over a period of time. Regulatory documents indicate that clinical response is often evaluated within 48 to 72 hours of starting treatment in research and clinical settings.


Q: Why do some people get a rash when taking Amoxicilina Rowe?

A: Regulatory documents describe two main reasons for a rash. It can be a common hypersensitivity reaction, which is an allergic response to penicillin-class medicines. It can also be a non-allergic rash that is known to occur very frequently in patients who have infectious mononucleosis while using the medication.


Q: Does Amoxicilina Rowe interact with alcohol?

A: The official labeling for amoxicillin does not include a specific documented chemical interaction with alcohol. However, alcohol consumption may sometimes worsen general side effects associated with the drug.


Q: Can Amoxicilina Rowe be used for dental infections?

A: The active ingredient amoxicillin is officially indicated in regulatory documents for the treatment of various infections. While specific dental uses may not be listed directly on all labels, clinical guidelines from authoritative bodies support its use for treating certain types of odontogenic (dental) infections.


Q: Is Amoxicilina Rowe the same as regular amoxicillin?

A: Amoxicilina Rowe contains the active ingredient amoxicillin. The drug is an amoxicillin-containing product. The 'Rowe' part of the name indicates the manufacturer or product line.


Q: What should I expect to feel when Amoxicilina Rowe starts working?

A: The drug starts working shortly after administration by blocking the growth and causing the death of susceptible bacteria. Patients may begin to notice the evolution of their symptoms, such as decreasing pain or fever, as measured in clinical trials, typically within the first two or three days of starting the treatment regimen.


Q: What should I do if my symptoms do not improve after a few days on Amoxicilina Rowe?

A: Official patient information often describes contacting a healthcare provider as the necessary next step if symptoms do not start to improve within a few days of beginning the treatment, or if the symptoms get worse.


Q: Does Amoxicilina Rowe cause yeast infections?

A: Yes, regulatory documents report the occurrence of vaginal yeast infections, also known as candidiasis, as a known adverse reaction to the medication. This effect is generally categorized as a less common side effect.


Q: Is it normal to feel tired while using Amoxicilina Rowe?

A: Tiredness, or fatigue, is not typically listed as a common stand-alone side effect on the regulatory label. However, it is mentioned as a possible symptom associated with some rare, serious adverse events, or as part of the systemic response to the underlying infection itself.


Q: Can Amoxicilina Rowe affect the results of blood tests?

A: Official documents note that high concentrations of amoxicillin in the urine can lead to false-positive results when using non-enzymatic urine glucose tests (such as CLINITEST®). The medicine is not typically reported to interfere with the results of general blood tests.


Q: Is it safe to drive or operate machinery while taking Amoxicilina Rowe?

A: The active ingredient amoxicillin has the potential to cause side effects such as dizziness and, rarely, convulsions (seizures). Because of these potential central nervous system (CNS) effects, regulatory authorities advise that the drug may have a minor or moderate influence on the ability to drive or use machinery.


Q: Are there studies on how Amoxicilina Rowe affects long-term health?

A: Research summaries in regulatory documents indicate that the long-term effects of the drug beyond the resolution of the acute infection are not fully established. This is because the follow-up period in most clinical studies was often limited to assessing the resolution of the immediate episode and preventing recurrence.


Q: Why is the drug named Amoxicilina Rowe?

A: The name exists to clearly identify the medicine as containing the active pharmaceutical ingredient, amoxicillin (or amoxicilina), and linking it to the company that manufactures or distributes the specific product, Rowe.


Q: How is the strength of Amoxicilina Rowe determined?

A: Regulatory documents define the strength of the medication based on the milligrams (mg) of the active ingredient contained in the dosage unit. For example, the strength reflects the amount of amoxicillin in each tablet, capsule, or specific volume of the oral suspension.


Q: Can I take Amoxicilina Rowe if I have a history of liver issues?

A: Regulatory documents note the possibility of rare hepatobiliary effects, such as liver inflammation or jaundice, which affects the liver and bile ducts. However, because the drug is primarily eliminated from the body by the kidneys, a specific dose adjustment for isolated liver issues is not typically required in the official guidance.


Q: Can Amoxicilina Rowe be taken with milk or dairy products?

A: Official directions for use state that the medicine may be taken with or without food. There is no regulatory warning or instruction to specifically avoid milk or other dairy products to ensure the proper absorption of the drug.


Q: Can Amoxicilina Rowe affect sleep?

A: While common sleep disturbances or insomnia are not listed as frequent side effects, the product label documents potential central nervous system (CNS) effects. These effects, including dizziness and, rarely, convulsions, could indirectly influence an individual's sleep quality or wakefulness.


Q: What distinguishes Amoxicilina Rowe from a delayed-release or extended-release version of amoxicillin?

A: Amoxicilina Rowe is typically an immediate-release oral formulation. This differs from extended-release versions, which are specially formulated to release the active ingredient slowly and are usually taken once a day according to official dosing requirements.


Q: Are there special warnings for patients with asthma taking Amoxicilina Rowe?

A: Regulatory warnings highlight that hypersensitivity reactions (allergic responses) are more likely to occur in individuals who have a history of sensitivity to multiple allergens. This group often includes patients with a history of allergic conditions such as asthma.


Q: What if I vomit shortly after using Amoxicilina Rowe?

A: Vomiting is documented in regulatory sources as an uncommon gastrointestinal adverse reaction. If this occurs shortly after taking a dose, it is a key clinical consideration as it could affect the total amount of medication absorbed by the body.


Q: Does Amoxicilina Rowe have an impact on gut flora?

A: Because the drug's mechanism is to destroy susceptible bacteria, its action can also affect the balance of natural, non-pathogenic microorganisms, often called gut flora. This disturbance is the reason why adverse effects such as diarrhea and, more rarely, severe colitis are documented safety warnings.


Q: Is the 'Rowe' part of the name important?

A: Yes, the 'Rowe' part of the name is important because it identifies the company responsible for the specific product, Amoxicilina Rowe, which includes the active drug amoxicillin. This ensures clear accountability for the specific formulation.


Q: What are the common misunderstandings about how Amoxicilina Rowe should be used?

A: A common misunderstanding addressed by authoritative patient information is that the drug is an antibiotic, meaning it is designed to treat only bacterial infections. It is ineffective against viral infections, such as the common cold or flu.


Q: Is Amoxicilina Rowe a broad-spectrum antibiotic?

A: Regulatory documents describe amoxicillin as an amino-penicillin class antibiotic. This means it is active against a wide variety of bacteria, which is the definition used for a broad-spectrum agent.

Advertisements

How should Amoxicilina Rowe be stored and disposed of?

Storage and Disposal

Solid forms (capsules, tablets, and dry powder) must be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). The medication should be kept in a tightly closed container and protected from excessive heat and moisture.

After reconstitution, the oral suspension requires storage in a refrigerator (2 C to 8 C) and must not be frozen. The refrigerated suspension is stable for 14 days, while storage at room temperature typically limits stability to 10 days. All forms must be stored out of the sight and reach of children.

Disposal of unused or expired product should follow local regulatory guidelines. Medicines should generally not be discarded via household waste or wastewater unless specifically instructed by local authorities.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amoxicilina Rowe found in:

A-Z Index: